[HTML][HTML] Biomarkers in the diagnosis of pancreatic cancer: Are we closer to finding the golden ticket?

RS O'Neill, A Stoita�- World journal of gastroenterology, 2021 - ncbi.nlm.nih.gov
Pancreatic cancer (PC) is a leading cause of cancer related mortality on a global scale. The
disease itself is associated with a dismal prognosis, partly due to its silent nature resulting in�…

[HTML][HTML] RANKL/RANK/OPG system beyond bone remodeling: involvement in breast cancer and clinical perspectives

M Infante, A Fabi, F Cognetti, S Gorini, M Caprio…�- Journal of Experimental�…, 2019 - Springer
Abstract RANKL/RANK/OPG system consists of three essential signaling molecules: i) the
receptor activator of nuclear factor (NF)-kB-ligand (RANKL), ii) the receptor activator of NF�…

The role of receptor activator of nuclear factor-κB (RANK)/RANK ligand/osteoprotegerin: clinical implications

D Vega, NM Maalouf, K Sakhaee�- The Journal of Clinical�…, 2007 - academic.oup.com
Context: Receptor activator of nuclear factor-κB ligand (RANKL), receptor activator of
nuclear factor-κB (RANK), and osteoprotegerin (OPG) play a central role in bone remodeling�…

Rank/Rankl/opg: literature review.

I Silva, JC Branco�- Acta reumatologica portuguesa, 2011 - search.ebscohost.com
The discovery of the receptor activator of nuclear factor-kB (RANK)/RANK Ligand (RANKL)/
osteoprotegerin (OPG) pathway contributed to the understanding of how bone formation and�…

Clinical significance of osteoprotegerin expression in human colorectal cancer

S Tsukamoto, T Ishikawa, S Iida, M Ishiguro…�- Clinical cancer�…, 2011 - AACR
Purpose: This study aimed to identify a novel biomarker or a target of treatment for colorectal
cancer (CRC). Experimental Design: The expression profiles of cancer cells in 104 patients�…

Expression of RANKL/RANK/OPG in primary and metastatic human prostate cancer as markers of disease stage and functional regulation

G Chen, K Sircar, A Aprikian, A Potti, D Goltzman…�- Cancer, 2006 - Wiley Online Library
BACKGROUND Late‐stage prostate cancer patients are refractory to hormone therapy and
exhibit a high propensity to develop skeletal metastasis. In this regard, the role of a novel�…

The RANK/RANKL/OPG triad in cancer-induced bone diseases

WC Dougall, M Chaisson�- Cancer and Metastasis Reviews, 2006 - Springer
The maintenance of skeletal integrity in a healthy individual requires a balanced regulation
of the processes of bone formation, mediated by osteoblasts, and bone resorption, mediated�…

The RANK/RANKL/OPG system in tumorigenesis and metastasis of cancer stem cell: potential targets for anticancer therapy

M Sisay, G Mengistu, D Edessa�- OncoTargets and therapy, 2017 - Taylor & Francis
The molecular triad involving receptor activator of nuclear factor kβ (RANK)/RANK ligand
(RANKL)/osteoprotegerin cytokine system has been well implicated in several physiological�…

Engagement of TRAIL triggers degranulation and IFNγ production in human natural killer cells

J H�fle, T Trenkner, N Kleist, V Schwane, S Vollmers…�- EMBO�…, 2022 - embopress.org
NK cells utilize a large array of receptors to screen their surroundings for aberrant or virus‐
infected cells. Given the vast diversity of receptors expressed on NK cells we seek to identify�…

[HTML][HTML] The role of osteoprotegerin (OPG) in fibrosis: its potential as a biomarker and/or biological target for the treatment of fibrotic diseases

H Habibie, A Adhyatmika, D Schaafsma…�- Pharmacology &�…, 2021 - Elsevier
Fibrosis is defined by excessive formation and accumulation of extracellular matrix proteins,
produced by myofibroblasts, that supersedes normal wound healing responses to injury and�…